1. Home
  2. QSG vs ZNTL Comparison

QSG vs ZNTL Comparison

Compare QSG & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QSG
  • ZNTL
  • Stock Information
  • Founded
  • QSG 2019
  • ZNTL 2014
  • Country
  • QSG China
  • ZNTL United States
  • Employees
  • QSG N/A
  • ZNTL N/A
  • Industry
  • QSG Other Consumer Services
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • QSG Real Estate
  • ZNTL Health Care
  • Exchange
  • QSG Nasdaq
  • ZNTL Nasdaq
  • Market Cap
  • QSG 140.0M
  • ZNTL 137.9M
  • IPO Year
  • QSG 2023
  • ZNTL 2020
  • Fundamental
  • Price
  • QSG $4.28
  • ZNTL $1.29
  • Analyst Decision
  • QSG
  • ZNTL Buy
  • Analyst Count
  • QSG 0
  • ZNTL 8
  • Target Price
  • QSG N/A
  • ZNTL $8.53
  • AVG Volume (30 Days)
  • QSG 2.3M
  • ZNTL 927.8K
  • Earning Date
  • QSG 06-05-2025
  • ZNTL 05-06-2025
  • Dividend Yield
  • QSG 4.71%
  • ZNTL N/A
  • EPS Growth
  • QSG 101.59
  • ZNTL N/A
  • EPS
  • QSG 1.04
  • ZNTL N/A
  • Revenue
  • QSG $477,141,565.00
  • ZNTL $67,425,000.00
  • Revenue This Year
  • QSG N/A
  • ZNTL N/A
  • Revenue Next Year
  • QSG $6.09
  • ZNTL N/A
  • P/E Ratio
  • QSG $4.13
  • ZNTL N/A
  • Revenue Growth
  • QSG N/A
  • ZNTL N/A
  • 52 Week Low
  • QSG $1.47
  • ZNTL $1.01
  • 52 Week High
  • QSG $7.96
  • ZNTL $13.46
  • Technical
  • Relative Strength Index (RSI)
  • QSG 55.22
  • ZNTL 39.50
  • Support Level
  • QSG $3.88
  • ZNTL $1.01
  • Resistance Level
  • QSG $4.74
  • ZNTL $1.32
  • Average True Range (ATR)
  • QSG 0.99
  • ZNTL 0.14
  • MACD
  • QSG -0.09
  • ZNTL 0.02
  • Stochastic Oscillator
  • QSG 18.40
  • ZNTL 37.33

About QSG QuantaSing Group Limited

QuantaSing Group Ltd is a learning service provider in China's adult learning market for personal interest courses. It offers easy-to-understand, affordable, and accessible online courses to adult learners under various brands, including QiNiu, Kelly, and QianChi among others empowering them to pursue personal development. The company offers courses for various domains such as financial literacy, skill upgrading, recreation, and leisure which are offered in live large-class dual-instructor mode, online community-based training camp mode, and in live lecture, one-on-one tutoring mode. Its segments are; Learning service and others which derives key revenue, and Consumer business. Geographically, the company generates all of its revenue from the People's Republic of China.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

Share on Social Networks: